The Efficacy of Umbelliferone, Arbutin, and N-Acetylcysteine to Prevent Microbial Colonization and Biofilm Development on Urinary Catheter Surface: Results from a Preliminary Study
Open Access
- 5 April 2016
- journal article
- research article
- Published by Hindawi Limited in Journal of Pathogens
- Vol. 2016, 1-6
Abstract
We evaluated, in a preliminary study, the efficacy of umbelliferone, arbutin, and N-acetylcysteine to inhibit biofilm formation on urinary catheter. We used 20 urinary catheters: 5 catheters were incubated withEnterococcus faecalis(control group); 5 catheters were incubated withE. faecalisin presence of umbelliferone (150 mg), arbutin (60 mg), and N-acetylcysteine (150 mg) (group 1); 5 catheters were incubated withE. faecalisin presence of umbelliferone (150 mg), arbutin (60 mg), and N-acetylcysteine (400 mg) (group 2); and 5 catheters were incubated withE. faecalisin presence of umbelliferone (300 mg), arbutin (60 mg), and N-acetylcysteine (150 mg) (group 3). After 72 hours, planktonic microbial growth and microorganisms on catheter surface were assessed. In the control group, we found a planktonic load of ≥105 CFU/mL in the inoculation medium and retrieved 3.69 × 106 CFU/cm from the sessile cells adherent to the catheter surface. A significantly lower amount in planktonic () and sessile () bacterial load was found in group 3, showing <100 CFU/mL and 0.12 × 106 CFU/cm in the incubation medium and on the catheter surface, respectively. In groups 1 and 2, 1.67 × 106 CFU/cm and 1.77 × 106 CFU/cm were found on catheter surface. Our results document that umbelliferone, arbutin, and N-acetylcysteine are able to reduceE. faecalisbiofilm development on the surface of urinary catheters.
Keywords
This publication has 30 references indexed in Scilit:
- Novel Approaches to the Diagnosis, Prevention, and Treatment of Medical Device-Associated InfectionsInfectious Disease Clinics of North America, 2012
- Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcificationsFEMS Immunology & Medical Microbiology, 2010
- Mucoactive drugsEuropean Respiratory Review, 2010
- Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections: Correlation of In Vivo and In Vitro Test ResultsAntimicrobial Agents and Chemotherapy, 2009
- Cranberry and Urinary Tract InfectionsDrugs, 2009
- Urinary Excretion and Metabolism of Arbutin after Oral Administration of Arctostaphylos uvae ursi Extract as Film‐Coated Tablets and Aqueous Solution in Healthy HumansThe Journal of Clinical Pharmacology, 2002
- Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic SurfacesInfection and Immunity, 2002
- A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGINI–04 study)Clinical Microbiology and Infection, 2001
- Examination of coumarins, flavonoids and polysaccharopeptide for antibacterial activityGeneral Pharmacology: The Vascular System, 1996
- UNTERSUCHUNGEN ZUR FRAGE DER HARNDESINFIZIERENDEN WIRKUNGEN VON BÄRENTRAUBENBLATT–EXTRAKTEN1Planta Medica, 1970